Paper Details 
Original Abstract of the Article :
Treatment discontinuation is a major challenge in routine clinical settings. Despite poor adherence to antipsychotic medication, long acting injectable (LAI) formulations are an underutilized option in psychotic disorders. Recently, an earlier and broader use of LAIs has been emphasized. However, fe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953565/

データ提供:米国国立医学図書館(NLM)

Tackling Treatment Discontinuation in Psychotic Disorders

This research investigates the challenge of treatment discontinuation in patients with psychotic disorders, a problem that can significantly impact their long-term recovery and wellbeing. Imagine a desert traveler who needs to stay hydrated, but keeps forgetting to carry water. This analogy highlights the struggle of maintaining consistent medication adherence in patients with psychosis. The authors explore the factors associated with discontinuation of long-acting injectable (LAI) antipsychotics, a promising treatment approach that aims to improve adherence. They found a substantial discontinuation rate within a year, emphasizing the need for further research to understand the factors driving this phenomenon and to develop strategies to improve adherence.

The Importance of Personalized Approaches in Medication Adherence

This research underscores the need for personalized approaches in medication adherence for patients with psychotic disorders. By understanding the factors that contribute to discontinuation, clinicians can tailor their treatment strategies to better support patient adherence and improve long-term outcomes. This study serves as a reminder that medication adherence is a crucial component of successful treatment and that addressing individual needs is vital for achieving optimal results.

Improving Patient Care in Psychotic Disorders

The study's findings highlight the need for innovative strategies to improve medication adherence in patients with psychotic disorders. By combining pharmacological treatments with individualized psychosocial interventions, clinicians can better support patients and encourage long-term engagement in their treatment. This research paves the way for a more holistic and patient-centered approach to managing psychotic disorders.

Dr. Camel's Conclusion

This research, like a desert oasis offering respite to a weary traveler, sheds light on the challenges of treatment adherence in patients with psychotic disorders. By understanding the factors contributing to discontinuation, we can develop more effective interventions and empower patients to navigate the journey towards recovery. Remember, just as a camel needs a steady supply of water to survive the desert, patients with psychosis need consistent support and care to manage their condition effectively.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-02-28
Further Info :

Pubmed ID

36830850

DOI: Digital Object Identifier

PMC9953565

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.